280 related articles for article (PubMed ID: 25137236)
1. Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis.
Rojas-Villarraga A; Torres-Gonzalez JV; Ruiz-Sternberg ÁM
PLoS One; 2014; 9(8):e104303. PubMed ID: 25137236
[TBL] [Abstract][Full Text] [Related]
2. Use of exogenous estrogens in systemic lupus erythematosus.
Mok CC; Lau CS; Wong RW
Semin Arthritis Rheum; 2001 Jun; 30(6):426-35. PubMed ID: 11404826
[TBL] [Abstract][Full Text] [Related]
3. [Estrogen use in systemic lupus erythematosus].
Ketari S; Cherif O; Boussema F; Kochbati S; Ben Dhaou B; Rokbani L
Gynecol Obstet Fertil; 2005 Oct; 33(10):783-90. PubMed ID: 16139552
[TBL] [Abstract][Full Text] [Related]
4. Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy.
Petri M
Lupus; 2001; 10(3):222-6. PubMed ID: 11315357
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of cervical HPV infection in women with systemic lupus erythematosus: A systematic review and meta-analysis.
García-Carrasco M; Mendoza-Pinto C; Rojas-Villarraga A; Molano-González N; Vallejo-Ruiz V; Munguía-Realpozo P; Colombo AL; Cervera R
Autoimmun Rev; 2019 Feb; 18(2):184-191. PubMed ID: 30572140
[TBL] [Abstract][Full Text] [Related]
6. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS
Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Chock YP; Moulinet T; Dufrost V; Erkan D; Wahl D; Zuily S
Autoimmun Rev; 2019 Nov; 18(11):102395. PubMed ID: 31520800
[TBL] [Abstract][Full Text] [Related]
8. [Hormonal therapy in systemic lupus erythematosus].
Kaliterna DM; Krstulović DM; Radić M
Reumatizam; 2009; 56(2):41-3. PubMed ID: 20429261
[TBL] [Abstract][Full Text] [Related]
9. Estrogen therapy in systemic lupus erythematosus.
Askanase AD
Treat Endocrinol; 2004; 3(1):19-26. PubMed ID: 15743110
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus.
Meier CR; Sturkenboom MC; Cohen AS; Jick H
J Rheumatol; 1998 Aug; 25(8):1515-9. PubMed ID: 9712093
[TBL] [Abstract][Full Text] [Related]
11. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus.
Buyon JP
J Am Med Womens Assoc (1972); 1998; 53(1):13-7. PubMed ID: 9458619
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis.
Giambalvo S; Garaffoni C; Silvagni E; Furini F; Rizzo R; Govoni M; Bortoluzzi A
Autoimmun Rev; 2022 Apr; 21(4):103038. PubMed ID: 34995765
[TBL] [Abstract][Full Text] [Related]
14. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.
Buyon JP; Petri MA; Kim MY; Kalunian KC; Grossman J; Hahn BH; Merrill JT; Sammaritano L; Lockshin M; Alarcón GS; Manzi S; Belmont HM; Askanase AD; Sigler L; Dooley MA; Von Feldt J; McCune WJ; Friedman A; Wachs J; Cronin M; Hearth-Holmes M; Tan M; Licciardi F
Ann Intern Med; 2005 Jun; 142(12 Pt 1):953-62. PubMed ID: 15968009
[TBL] [Abstract][Full Text] [Related]
15. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
[TBL] [Abstract][Full Text] [Related]
16. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of biologic therapies for systemic lupus erythematosus treatment: systematic review and meta-analysis.
Borba HH; Wiens A; de Souza TT; Correr CJ; Pontarolo R
BioDrugs; 2014 Apr; 28(2):211-28. PubMed ID: 24190520
[TBL] [Abstract][Full Text] [Related]
18. [Use of estrogen in women with systemic lupus erythematosus--should, should not?].
Ostensen M
Tidsskr Nor Laegeforen; 1996 Nov; 116(27):3237-9. PubMed ID: 9011978
[TBL] [Abstract][Full Text] [Related]
19. Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis.
Charoenngam N; Ponvilawan B; Wongtrakul W; Ungprasert P
Clin Rheumatol; 2021 Feb; 40(2):529-536. PubMed ID: 32638252
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives and systemic lupus erythematosus: what should we advise to our patients?
Duarte C; Inês L
Acta Reumatol Port; 2010; 35(2):133-40. PubMed ID: 20711088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
